I9SA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Verona Pharma PLC

Watchlist Manager

Watchlist

Price: 90.2 EUR 0.67%

Market Cap: €7.3B

V	Verona Pharma PLC F:I9SA	UK
	Fox Corp F:FO5	US
	Sunnova Energy International Inc NYSE:NOVA	US
D	Discover Financial Services F:DC7	US
S	Synopsys Inc LSE:0LBP	US

Profitability Summary

Verona Pharma PLC's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

95%

Strong 3Y Average Gross Margin

62%

Negative Operating Margin

-25%

Negative 3Y Average Operating Margin

-5 165%

Operating Margin is Increasing

-16 022% > -25%

Negative Net Margin

-37%

Negative 3Y Average Net Margin

-4 261%

Net Margin is Increasing

-13 176% > -37%

Negative Free Cash Flow Margin

-33%

Negative 3Y Average Free Cash Flow Margin

-4 019%

Free Cash Flow Margin is Increasing

-11 122% > -33%

Negative ROE

-36%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-267%

ROIC is Increasing

-280% > -80%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.